Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 155051-155100 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT02249949
Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery
PHASE2
Completed
15 participants
Started: Feb 11, 2015 · Completed: May 1, 2023
1 condition
3 sponsors
127 locations
NCT02389062
Noninvasive Markers of Gluten Ingestion in Celiac Disease Patients
NA
Completed
5 participants
Started: Feb 11, 2015 · Completed: Feb 11, 2017
1 condition
1 sponsor
1 location
NCT03228797
A Comparison of Postoperative Outcomes Provided by a Continuous Preperitoneal Infusion Versus Ultrasound Guided Rectus Sheath Block for Midline Emergency Laparotomy
NA
Completed
60 participants
Started: Feb 11, 2015 · Completed: Sep 30, 2016
1 condition
1 sponsor
0 locations
NCT02317887
Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis
PHASE1/PHASE2
Completed
12 participants
Started: Feb 11, 2015 · Completed: Oct 16, 2024
2 conditions
2 sponsors
1 location
NCT02558036
Optimal Head and Neck Position During Videolaryngoscopy
NA
Completed
200 participants
Started: Feb 11, 2015 · Completed: Apr 27, 2017
1 condition
1 sponsor
1 location
NCT03114579
Evaluation of the Measurement of Cardiac Output by the NEXFIN HD Monitor in Peroperative
NA
Completed
42 participants
Started: Feb 11, 2015 · Completed: Feb 11, 2017
2 conditions
1 sponsor
1 location
NCT02333500
Oxytocin and Incitement to Use Olfactory Stimuli in Restrictive Anorexia Nervosa
NA
Completed
30 participants
Started: Feb 11, 2015 · Completed: Dec 31, 2018
1 condition
1 sponsor
1 location
NCT05151302
The Italian Version of the Computer-Vision Symptom Scale Questionnaire: Translation, Validation and Reliability.
NA
Completed
216 participants
Started: Feb 11, 2015 · Completed: Feb 6, 2017
2 conditions
1 sponsor
0 locations
NCT02300610
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
PHASE1
Completed
10 participants
Started: Feb 11, 2015 · Completed: Apr 19, 2019
5 conditions
1 sponsor
2 locations
NCT02201576
Bortezomib in Rejection of Kidney Transplants
PHASE2
Completed
60 participants
Started: Feb 11, 2015 · Completed: Jul 16, 2020
1 condition
2 sponsors
1 location
NCT05532202
A Mobile Web-Based Parenting Intervention to Strengthen Social-Emotional Development of Low Birth Weight Infants
NA
Completed
102 participants
Started: Feb 11, 2015 · Completed: Jun 16, 2017
3 conditions
2 sponsors
0 locations
NCT02021955
Integrating Care After Exacerbation of COPD
NA
Completed
717 participants
Started: Feb 11, 2015 · Completed: Jan 31, 2019
1 condition
1 sponsor
2 locations
NCT02371603
Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult Volunteers
PHASE1
Completed
70 participants
Started: Feb 11, 2015 · Completed: Aug 12, 2015
1 condition
1 sponsor
1 location
NCT02346240
Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)
PHASE3
Completed
559 participants
Started: Feb 11, 2015 · Completed: Dec 17, 2018
2 conditions
1 sponsor
70 locations
NCT03642938
Exercise Dosing for Pain in Healthy Participants
NA
Completed
41 participants
Started: Feb 11, 2015 · Completed: Jun 6, 2017
1 condition
2 sponsors
1 location
NCT02426879
Esophagectomy for Patients With Esophageal Cancer and Cervical Lymph Node Metastases
NA
Completed
20 participants
Started: Feb 11, 2015 · Completed: Jan 25, 2021
4 conditions
1 sponsor
1 location
NCT02167958
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
PHASE1
Completed
28 participants
Started: Feb 11, 2015 · Completed: Sep 21, 2019
4 conditions
1 sponsor
1 location
NCT02316340
Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer
PHASE2
Completed
42 participants
Started: Feb 11, 2015 · Completed: Apr 16, 2018
1 condition
1 sponsor
1 location
NCT02191397
Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder
PHASE3
Completed
534 participants
Started: Feb 10, 2015 · Completed: Oct 25, 2016
1 condition
1 sponsor
20 locations
NCT02377635
Selenium and Arsenic Pharmacodynamics
PHASE1/PHASE2
Completed
40 participants
Started: Feb 10, 2015 · Completed: Jan 19, 2017
1 condition
7 sponsors
1 location
NCT03258411
Evaluation Of Different Rapid Orthodontic Expansion Devices
PHASE1
Completed
31 participants
Started: Feb 10, 2015 · Completed: Apr 1, 2019
1 condition
1 sponsor
1 location
NCT02371980
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)
PHASE4
Completed
1,106 participants
Started: Feb 10, 2015 · Completed: Apr 25, 2019
1 condition
1 sponsor
79 locations
NCT02363972
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
NA
Completed
103 participants
Started: Feb 10, 2015 · Completed: Jun 30, 2016
4 conditions
1 sponsor
5 locations
NCT02330952
Efficacy of Corticosteroids to Treat Outpatients With Acute Exacerbations of COPD
PHASE4
Completed
189 participants
Started: Feb 10, 2015 · Completed: May 23, 2017
2 conditions
2 sponsors
1 location
NCT02672397
The Effect of a Culturally Sensitive Educational Intervention on Acceptance of Neuraxial Anesthesia
NA
Completed
200 participants
Started: Feb 10, 2015 · Completed: Dec 31, 2017
1 condition
1 sponsor
1 location
NCT02267382
A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
PHASE2
Completed
254 participants
Started: Feb 10, 2015 · Completed: Nov 9, 2016
1 condition
1 sponsor
32 locations
NCT02323139
A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients
PHASE1
Completed
23 participants
Started: Feb 10, 2015 · Completed: Aug 1, 2018
1 condition
2 sponsors
24 locations
NCT02315469
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery
N/A
Completed
190 participants
Started: Feb 10, 2015 · Completed: Feb 9, 2019
10 conditions
2 sponsors
393 locations
NCT02177136
Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
PHASE2
Completed
77 participants
Started: Feb 9, 2015 · Completed: Mar 22, 2018
1 condition
1 sponsor
36 locations
NCT02364726
Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients
NA
Completed
28 participants
Started: Feb 9, 2015 · Completed: Jun 21, 2023
2 conditions
1 sponsor
2 locations
NCT02364947
A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)
PHASE3
Completed
678 participants
Started: Feb 9, 2015 · Completed: Jul 30, 2016
1 condition
2 sponsors
7 locations
NCT03455634
Predictors Associated With Seeking Orthodontic Treatment, Compliance and Treatment Success
NA
Completed
110 participants
Started: Feb 9, 2015 · Completed: May 17, 2022
1 condition
3 sponsors
1 location
NCT02337491
Pembrolizumab +/- Bevacizumab for Recurrent GBM
PHASE2
Completed
80 participants
Started: Feb 9, 2015 · Completed: Sep 14, 2020
1 condition
1 sponsor
8 locations
NCT02311959
Therapeutic Nipple Sparing Mastectomy.
PHASE3
Completed
450 participants
Started: Feb 9, 2015 · Completed: Dec 4, 2024
1 condition
2 sponsors
33 locations
NCT02233517
Group CBT for Aggression in Veterans
NA
Completed
66 participants
Started: Feb 9, 2015 · Completed: Jul 5, 2017
3 conditions
1 sponsor
1 location
NCT02270736
Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability
PHASE3
Completed
256 participants
Started: Feb 9, 2015 · Completed: May 7, 2019
5 conditions
1 sponsor
31 locations
NCT02009436
Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
PHASE1
Completed
8 participants
Started: Feb 9, 2015 · Completed: Jul 18, 2018
2 conditions
2 sponsors
1 location
NCT02474069
Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis
PHASE3
Completed
772 participants
Started: Feb 8, 2015 · Completed: Sep 15, 2016
1 condition
1 sponsor
89 locations
NCT04265833
Evaluation of Three Different Pulp Capping Materials in Indirect Pulp Treatment of Primary Teeth
NA
Completed
109 participants
Started: Feb 8, 2015 · Completed: Jul 7, 2018
1 condition
1 sponsor
0 locations
NCT02344797
Prevention of Myocardial Injury in Non-cardiac Surgery
NA
Completed
573 participants
Started: Feb 7, 2015 · Completed: Aug 24, 2018
2 conditions
1 sponsor
3 locations
NCT02337725
A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients
PHASE3
Completed
244 participants
Started: Feb 7, 2015 · Completed: Sep 15, 2016
1 condition
1 sponsor
55 locations
NCT02624414
Capsule Colonoscopy in Crohn's Disease and Its Correlation With Conventional Colonoscopy and Faecal Calprotectin
NA
Completed
47 participants
Started: Feb 6, 2015 · Completed: May 5, 2022
1 condition
2 sponsors
1 location
NCT02215512
Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases
PHASE1
Completed
29 participants
Started: Feb 6, 2015 · Completed: Nov 12, 2020
1 condition
1 sponsor
5 locations
NCT02334553
Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma
PHASE2
Completed
12 participants
Started: Feb 6, 2015 · Completed: Nov 25, 2015
1 condition
1 sponsor
1 location
NCT02282020
Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments
PHASE3
Completed
266 participants
Started: Feb 6, 2015 · Completed: Jul 19, 2022
1 condition
3 sponsors
94 locations
NCT02196857
Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation
PHASE2
Completed
16 participants
Started: Feb 6, 2015 · Completed: Nov 27, 2018
1 condition
2 sponsors
1 location
NCT02387658
Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient
N/A
Completed
25 participants
Started: Feb 6, 2015 · Completed: Jul 13, 2016
2 conditions
1 sponsor
1 location
NCT02386540
Health Coach Program to Improve Chronic Disease Outcomes Following an Emergency Department Visit
NA
Completed
295 participants
Started: Feb 6, 2015 · Completed: Dec 10, 2018
2 conditions
3 sponsors
1 location
NCT02791997
Audition After a Lesion and in Migraine. (AuditionPostLesion)
NA
Completed
262 participants
Started: Feb 6, 2015 · Completed: Sep 9, 2020
1 condition
1 sponsor
2 locations
NCT02225119
The Focal Electro-Oculogram in Macular Disease
N/A
Completed
39 participants
Started: Feb 6, 2015 · Completed: Feb 28, 2020
2 conditions
1 sponsor
1 location
Previous
1
More pages
3099
3100
3101
3102
3103
3104
3105
More pages
6093
Next